Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2500${count})

  • Research Grant, 2025
    Clinical Evaluation of 18F-FD4 as a Potential Alpha-synuclein PET Imaging Biomarker
  • iPSC Phenotyping Environmental Exposure Program, 2025
    Assessing PD-relevant Toxicants on Neurons and Microglia and their Crosstalk

    Study Rationale: We know that genetics plays a role in risk of Parkinson’s disease (PD) but does not explain every case, leading to the suggestion that genes work within the context of other exposures...

  • Seed Amplification Assay Innovation Program, 2025
    Quantitative SAA for Measuring Disease Progression in Parkinson’s Disease from Plasma

    Study Rationale: Parkinson’s disease (PD) is associated with the accumulation of clumped alpha-synuclein (asyn) protein in the brain. Detecting asyn in blood plasma could provide a less invasive and...

  • Seed Amplification Assay Innovation Program, 2025
    A Robust, Quantitative SAA and its Clinical Application

    Study Rationale: Seed Amplification Assays (SAA) have shown impressive results in distinguishing people with Parkinson's disease from healthy individuals using a simple yes/no test. This test detects...

  • Seed Amplification Assay Innovation Program, 2025
    Quantitative Real-Time Alpha-synuclein Seed Detection by SeRAS®

    Study Rationale: Seed Amplification Assays (SAAs) can detect minute amounts of alpha-synuclein deposits (called seeds) in cerebrospinal fluid (CSF) and other biofluids of Parkinson’s patients. They...

  • Seed Amplification Assay Innovation Program, 2025
    Quantification of Seed Competent Alpha-synuclein in Body Fluids

    Study Rationale: Seed amplification assays (SAA) are very effective in helping to diagnose Parkinson’s where the alpha-synuclein protein is involved. Using “spinal tap” fluid (CSF), SAA can tell if a...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.